Strategies for reducing treatment default in drug-resistant tuberculosis: systematic review and meta-analysis.
about
Reminder systems to improve patient adherence to tuberculosis clinic appointments for diagnosis and treatmentImpact of Community-Based DOT on Tuberculosis Treatment Outcomes: A Systematic Review and Meta-AnalysisAssociation between Directly Observed Therapy and Treatment Outcomes in Multidrug-Resistant Tuberculosis: A Systematic Review and Meta-AnalysisDigital health for the End TB Strategy: developing priority products and making them work.Quality of Life, Psychological Interventions and Treatment Outcome in Tuberculosis Patients: The Indian ScenarioAggressive regimens for multidrug-resistant tuberculosis decrease all-cause mortalityRisk factors associated with default from multi- and extensively drug-resistant tuberculosis treatment, Uzbekistan: a retrospective cohort analysisAlcohol, hospital discharge, and socioeconomic risk factors for default from multidrug resistant tuberculosis treatment in rural South Africa: a retrospective cohort studyAre we doing enough to stem the tide of acquired MDR-TB in countries with high TB burden? Results of a mixed method study in Chongqing, ChinaLoss from treatment for drug resistant tuberculosis: risk factors and patient outcomes in a community-based program in Khayelitsha, South AfricaSuccessful Tuberculosis Treatment Outcomes among HIV/TB Coinfected Patients Down-Referred from a District Hospital to Primary Health Clinics in Rural South AfricaPatient Characteristics Associated with Tuberculosis Treatment Default: A Cohort Study in a High-Incidence Area of Lima, Peru"When Treatment Is More Challenging than the Disease": A Qualitative Study of MDR-TB Patient RetentionDirect Observation (DO) for Drug-Resistant Tuberculosis: Do We Really DO?Clinical Features and Treatment Outcomes of Patients with Drug-Resistant and Drug-Sensitive Tuberculosis: A Historical Cohort Study in Porto Alegre, BrazilMDR-TB treatment as prevention: The projected population-level impact of expanded treatment for multidrug-resistant tuberculosisUsing Survival Analysis to Identify Risk Factors for Treatment Interruption among New and Retreatment Tuberculosis Patients in Kenya.Monitoring Therapy Compliance of Tuberculosis Patients by using Video-Enabled Electronic Devices.DOT or SAT for Rifampicin-resistant tuberculosis? A non-randomized comparison in a high HIV-prevalence setting.Beyond UHC: monitoring health and social protection coverage in the context of tuberculosis care and prevention.Community-based care vs. centralised hospitalisation for MDR-TB patients, KwaZulu-Natal, South Africa.Association between health systems performance and treatment outcomes in patients co-infected with MDR-TB and HIV in KwaZulu-Natal, South Africa: implications for TB programmes"I can also serve as an inspiration": a qualitative study of the TB&Me blogging experience and its role in MDR-TB treatment.Multidrug-resistant tuberculosis: Treatment and outcomes of 93 patients.The need to accelerate access to new drugs for multidrug-resistant tuberculosis.Achieving high treatment success for multidrug-resistant TB in Africa: initiation and scale-up of MDR TB care in Ethiopia--an observational cohort study.The scourge of tuberculosis and anti-tuberculosis drug resistance in Eastern EuropeRisk factors associated with loss to follow-up among multidrug-resistant tuberculosis patients in Georgia.Poor treatment outcomes among multidrug-resistant tuberculosis patients in Gomel Region, Republic of BelarusThe Effects of Psycho-Emotional and Socio-Economic Support for Tuberculosis Patients on Treatment Adherence and Treatment Outcomes - A Systematic Review and Meta-AnalysisWhere there is hope: a qualitative study examining patients' adherence to multi-drug resistant tuberculosis treatment in Karakalpakstan, UzbekistanMultidrug-Resistant Tuberculosis Treatment in North Korea: Is Scale-Up Possible?Early Outcomes Of Decentralized Care for Rifampicin-Resistant Tuberculosis in Johannesburg, South Africa: An Observational Cohort StudyDevelopment of a Patient-Centred, Psychosocial Support Intervention for Multi-Drug-Resistant Tuberculosis (MDR-TB) Care in Nepal.Risk factors for poor multidrug-resistant tuberculosis treatment outcomes in Kyiv Oblast, Ukraine.Global Progress and Challenges in Implementing New Medications for Treating Multidrug-Resistant Tuberculosis.Factors Associated with Loss to Follow-up during Treatment for Multidrug-Resistant Tuberculosis, the Philippines, 2012-2014Economic support to patients in HIV and TB grants in rounds 7 and 10 from the global fund to fight AIDS, tuberculosis and malaria.Expected effects of adopting a 9 month regimen for multidrug-resistant tuberculosis: a population modelling analysis.A systematic review and meta-analysis of the efficacy and safety of N-acetylcysteine in preventing aminoglycoside-induced ototoxicity: implications for the treatment of multidrug-resistant TB.
P2860
Q24187942-F913F792-19F2-4AAA-BCA0-371A4F3F1E1AQ26768578-17148E05-8259-4C7A-8BAB-126CFCF4C4B3Q27013703-96CD80E4-09E6-4474-B909-67AB0B17FB38Q27321528-E4DC440A-E628-48D0-B493-2F3776341A13Q28075347-D1645B8B-4A73-42AF-8332-FFD61D1A36CDQ28487938-D0C80227-662E-4270-A68B-966B7EFD1794Q28534902-10E72013-BA25-487A-A257-EDBAC19E64BCQ28537696-EAABA999-6C9D-49CC-A3D8-76DAD27019C5Q28539576-87A7A262-8D6B-4D82-87D0-6B0B3F7471E3Q28544642-D4437FD0-B58B-4CB4-8B31-2AE7D111C190Q28547344-225CC590-24F8-4E82-8D77-307A7669D7E0Q28547965-DF4E002B-398F-4766-B5B4-807500524640Q28550630-23475496-F130-4FB6-9672-DEA030577DE3Q28552094-0A7F8E21-B91A-46B6-B81F-0F48D9A5B4EFQ28553427-79BD98DF-13EC-4355-945D-CD12C12C2A59Q29247878-F383F9A4-BE39-4137-B0BE-675773F941A7Q30380905-1A17B1C4-1D4B-4C26-BC28-2E59C827E605Q33447312-DAD13BA1-264F-4C85-89EF-1F54FC8486F4Q33704314-B4A227B4-9CEC-4394-AA14-9332D3DBF355Q34226104-5A4E27E0-FAB2-459B-9445-7B27AE8BF15CQ35072895-BBEEEBE4-533C-419F-8B22-FC29CD2FAD16Q35144014-0D7F9ED9-B724-49AA-83D2-12FB72E61B5AQ35273993-BB2672FF-8368-449E-8FA1-AD476C11A6FDQ35322061-D34F5CEC-F85A-4EE1-AC75-EB49414CC756Q35815071-78E8A46D-5738-48A8-9F88-26E907E01DAFQ35823335-69C91849-B953-4CB0-ABF2-8D044E27F122Q35990625-6559A9CE-646D-427A-BB67-4D0AB28B8333Q35990631-0F7CEC69-3730-4D05-9887-A6EDCC6C76FAQ35990676-3A5FED4E-B17C-4BB8-9221-380A35B198F6Q36001697-22F1DC65-2523-494F-ACAE-0649569CEC64Q36088019-51BDB850-2EE6-42FE-899F-5D584B0ECB34Q36092543-F6DC3A3A-A859-4A64-8320-18C04361C87FQ36182135-C29F05F8-EEFB-49CA-8FEE-61C2F4F74F91Q36252706-9F7DAF5F-AAE8-4296-BBE7-45E2302BDEF3Q36273236-E6118ED3-E146-487A-9954-F74B9F34D318Q36617024-954403AA-8338-466E-9144-3A18E2822DEAQ36617035-067009A2-577D-4B08-BEBE-113C9CB27D3DQ37525186-CFC50BBE-7AEA-4F4B-B77C-9F2ED5B5BF8DQ37675764-B4946C07-AF97-4A6E-8B65-D5396583261CQ38582633-E0C30D16-C630-4982-B9C7-A326F3830934
P2860
Strategies for reducing treatment default in drug-resistant tuberculosis: systematic review and meta-analysis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Strategies for reducing treatm ...... atic review and meta-analysis.
@en
type
label
Strategies for reducing treatm ...... atic review and meta-analysis.
@en
prefLabel
Strategies for reducing treatm ...... atic review and meta-analysis.
@en
P2093
P31
P356
P1476
Strategies for reducing treatm ...... matic review and meta-analysis
@en
P2093
P304
P356
10.5588/IJTLD.12.0537
P577
2012-12-04T00:00:00Z